Skip to main content
. Author manuscript; available in PMC: 2019 May 29.
Published in final edited form as: N Engl J Med. 2018 Oct 10;379(22):2131–2139. doi: 10.1056/NEJMoa1714458

Table 2.

Diagnoses According to Method.

Diagnosis Patients with
Complete Evaluation
(N = 382)
no./total no. (%)
Diagnosis by any method 132/382 (35)
Clinical review 15/132 (11)
Directed clinical testing 14/132 (11)
Nonsequencing genomewide diagnostic assay 5/132 (4)
Exome or genome sequencing* 98/132 (74)
   Reanalysis of previously obtained sequencing data 11/132 (8)
   Exome sequencing through the UDN 55/132 (42)
    Had previously undergone exome sequencing 6/132 (5)
   Genome sequencing through the UDN 32/132 (24)
    Had previously undergone exome sequencing 17/132 (13)
No diagnosis 250/382 (65)
*

One diagnosis was established by both exome and genome sequencing.